<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;A07X&quot;,&quot;href&quot;:&quot;atc/A07X.md&quot;},{&quot;label&quot;:&quot;ceratonia&quot;}]"></div>

# ceratonia

- **generic name:** ceratonia
- **ATC codes:** `A07XA02`
- **DrugBank:** not captured · **PubChem:** not captured
- **groups:** not captured

## About

Ceratonia (carob) is a plant genus whose products are used as an antidiarrheal remedy. It is classified as an other antidiarrheal for the alimentary tract, and remains in use as a traditional remedy.

<small>Summary written by `glm-5.3-flash` from [Wikidata Q159376](https://www.wikidata.org/wiki/Q159376) and the WHO ATC classification; not checked by a person.</small>

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-04 20:25 | 6:56 | 0/0/0 | 1/0/0 | 0/0/0 | 272,254/5,645 | ollama / qwen3.8:27b-mtp-q8_0 | 46 | 9/27 | 44/2 | 0 |

## popPK records

_not available_

## Pharmacodynamics (PD)

| status | detail | about | model | citation | doi |
|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--green">extracted</span> <span class="pk-badge pk-badge--species" title="In-vitro data (cells, tissue or microsomes), not measured in people (from an LLM reading of the title and abstract by gpt-6-luna, p(non-human) 1.00).">in vitro</span> | [Elazab_2022_GI](drugs/drug_ceratonia/pd_Elazab_2022_GI.md) | % Inhibition of T. gondii RH ← Ceratonia siliqua · inhibition effect | — | Elazab ST et al., Anti-Toxoplasma Activities of Some Egyp…, Acta parasitologica (2022) | [10.1007/s11686-022-00633-2](https://doi.org/10.1007/s11686-022-00633-2) |

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr><tr><td><span class="pk-badge pk-badge--species">rat</span></td><td>the data come from an animal (or in-vitro) study, not from people. The record, its model and its simulation are kept — they describe that species.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 33 matched, 100 returned
- **screened:** 1  ·  **relevant:** 1
- **records:** 0  ·  extracted 0  ·  needs_review 0  ·  rejected 0  ·  stale 0
- **scholar-agent fallback query used:** True

## Full text wanted

_5 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Sassi_2016.pdf` | Sassi A et al., Assessment in vitro of the genotoxicity…, Regulatory toxicology and p… (2016) | pd | 5 | [10.1016/j.yrtph.2016.02.009](https://doi.org/10.1016/j.yrtph.2016.02.009) | [26946406](https://www.ncbi.nlm.nih.gov/pubmed/26946406) | metadata signals extractable PD data (EC50) |
| `Lall_2015.pdf` | Lall N et al., Extract from Ceratonia siliqua Exhibits…, Phytotherapy research : PTR (2015) | pd | 4 | [10.1002/ptr.5420](https://doi.org/10.1002/ptr.5420) | [26201055](https://www.ncbi.nlm.nih.gov/pubmed/26201055) | metadata signals extractable PD data (IC50) |
| `Meziani_2015.pdf` | Meziani S et al., Antibacterial activity of carob (Cerato…, Microbial pathogenesis (2015) | pd | 4 | [10.1016/j.micpath.2014.12.001](https://doi.org/10.1016/j.micpath.2014.12.001) | [25489722](https://www.ncbi.nlm.nih.gov/pubmed/25489722) | metadata signals extractable PD data (IC50) |
| `Peng_2023.pdf` | Peng ZT et al., Novel phenylpropanoids and isoflavone g…, Natural product research (2023) | pd | 4 | [10.1080/14786419.2022.2076230](https://doi.org/10.1080/14786419.2022.2076230) | [35574610](https://www.ncbi.nlm.nih.gov/pubmed/35574610) | metadata signals extractable PD data (IC50) |
| `Serio_2025.pdf` | Serio S et al., Carob (Ceratonia siliqua) leaves: A com…, Food chemistry (2025) | pd | 4 | [10.1016/j.foodchem.2024.142392](https://doi.org/10.1016/j.foodchem.2024.142392) | [39667236](https://www.ncbi.nlm.nih.gov/pubmed/39667236) | metadata signals extractable PD data (IC50) |

<sub>queue written 2026-10-04T20:24:24.233235+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Aktaş_2024 | irrelevant | 0 | 0 | The paper focuses on the encapsulation of anthocyanins using potato protein coacervates and does not involve the drug ceratonia or any pharmacokinetic modeling. |
| popPK | Al_2025 | irrelevant | 0 | 0 | The study investigates the effects of flaxseed, melatonin, gum acacia, and betaine on diabetic rats with CKD, and does not report pharmacokinetic parameters for ceratonia. |
| popPK | Ali_2010 | irrelevant | 0 | 0 | The study investigates the nephroprotective effects of Gum Arabic (Acacia senegal) on chronic renal failure in rats, not the pharmacokinetics of ceratonia. |
| popPK | Ali_2013 | irrelevant | 0 | 0 | The study investigates the nephroprotective effects of Gum Arabic (Acacia senegal) in rats, not the pharmacokinetics of ceratonia. |
| popPK | Ali_2014 | irrelevant | 0 | 0 | The study investigates the effect of gum acacia on anemia in adenine-induced chronic kidney disease in rats and does not report pharmacokinetic parameters for ceratonia. |
| popPK | Ali_2015 | irrelevant | 0 | 0 | The study investigates the effect of Gum Arabic on adenine-induced renal failure in rats and does not report pharmacokinetic parameters for ceratonia. |
| popPK | Alruwaili_2025 | irrelevant | 0 | 0 | The study investigates the therapeutic effects of gum acacia and dexamethasone on sepsis-induced acute kidney injury in rats, not the pharmacokinetics of ceratonia. |
| popPK | Annisa_2024 | irrelevant | 0 | 0 | The study evaluates the pharmacokinetics of ketoconazole, not ceratonia. |
| popPK | Bai_2023 | irrelevant | 0 | 0 | The study focuses on longan pulp polysaccharides and gut microbiota, not the pharmacokinetics of ceratonia. |
| popPK | Bennett_1987 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of Aspergillus galactomannan, not the drug ceratonia. |
| popPK | Bi_2022 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of Polygonatum sibiricum polysaccharide, not ceratonia. |
| popPK | Bruyn_1992 | irrelevant | 0 | 0 | The paper is a review of host defense mechanisms against Streptococcus pneumoniae and contains no pharmacokinetic data for ceratonia. |
| popPK | Cegledi_2022 | irrelevant | 0 | 0 | The paper studies the spray drying encapsulation and in vitro bioavailability of nettle leaf polyphenols, not the pharmacokinetics of the drug ceratonia. |
| popPK | Chikhaoui_2026 | irrelevant | 0 | 0 | The study focuses on the phytochemical profiling and antibacterial activity of honeys, not the pharmacokinetics of the drug ceratonia. |
| popPK | Couëdelo_2022 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of n-3 fatty acids (EPA/DHA) in rats, not the drug ceratonia. |
| popPK | Dobroslavić_2023 | irrelevant | 0 | 0 | The paper studies the physicochemical properties and in vitro bioaccessibility of Laurus nobilis (laurel) polyphenols, not the pharmacokinetics of ceratonia. |
| popPK | E_2020 | irrelevant | 0 | 0 | The study investigates the neuroprotective effects of curcumin formulations in a toxicity model and does not report pharmacokinetic parameters for ceratonia. |
| PD | El-Neketi_2013 | not_relevant | 2 | 2 | The paper reports a single IC50 value for a fungal metabolite (citriquinochroman) in a cytotoxicity assay, which is a pharmacological potency measurement, not a pharmacodynamic (exposure-response) model for the plant or a drug with derivable PD parameters like Emax or slope. |
| popPK | Elbialy_2022 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of curcumin, not ceratonia. |
| popPK | Fu_2023 | irrelevant | 0 | 0 | The paper studies the stability and bioavailability of anthocyanins from purple potatoes, not the pharmacokinetics of ceratonia. |
| popPK | Gali_2022 | irrelevant | 0 | 0 | The study focuses on the formulation and characterization of nanoparticles for rutin, not the pharmacokinetics of ceratonia. |
| popPK | Gangneux_2019 | irrelevant | 0 | 0 | no_text gate: only 297 chars of text extracted (&lt; 400) |
| PD | Gangneux_2019 | not_relevant | 0 | 0 | The text is a conference invitation and contains no pharmacodynamic data or analysis. |
| popPK | Gonda_1994 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding ceratonia or pharmacokinetics. |
| popPK | Guedes-da-Silva_2019 | irrelevant | 0 | 0 | The study focuses on the efficacy of VFV and benznidazole in treating Chagas disease in mice and does not report pharmacokinetic parameters for ceratonia. |
| popPK | Guo_2022 | irrelevant | 0 | 0 | The study focuses on the encapsulation and stability of curcumin in nanoparticles, not the pharmacokinetics of ceratonia. |
| popPK | Hassani_2020 | irrelevant | 0 | 0 | The paper studies gallic acid nanoparticles, not ceratonia, and contains no pharmacokinetic parameters for the target drug. |
| popPK | Hu_2021 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of tangeretin, not ceratonia. |
| popPK | Huang_2018 | irrelevant | 0 | 0 | The paper describes the synthesis and in-vitro characterization of galactomannan-iron complexes, not the pharmacokinetics of ceratonia. |
| popPK | Hudiyanti_2022 | irrelevant | 0 | 0 | The paper is an in-vitro study on curcumin encapsulation in gum Arabic and does not involve the drug ceratonia or report any pharmacokinetic parameters. |
| popPK | Hudiyanti_2024 | irrelevant | 0 | 0 | The paper is an in-vitro formulation study on curcumin encapsulation in liposomes and does not involve the drug ceratonia or report pharmacokinetic parameters. |
| PD | Jamous_2018 | not_relevant | 3 | 3 | The paper reports a single IC50 value (0.8 mg/mL) for Ceratonia siliqua leaves in an in vitro enzyme inhibition assay, which is a static potency metric rather than a dynamic pharmacodynamic (exposure-response) model or curve with derivable parameters like Emax or slope. |
| popPK | Jin_2022 | irrelevant | 0 | 0 | The paper studies the encapsulation of EGCG (epigallocatechin gallate) in nanoparticles, not the drug ceratonia, and contains no pharmacokinetic parameters. |
| popPK | Khalil_2024 | irrelevant | 0 | 0 | The study focuses on esculetin (a different drug) and does not report pharmacokinetic parameters for ceratonia. |
| popPK | King_1985 | irrelevant | 0 | 0 | The study is an in-vitro biomechanical model of mucus clearance using locust bean gum (ceratonia) as a mucus simulant, not a pharmacokinetic study of ceratonia as a drug. |
| popPK | King_1987 | irrelevant | 0 | 0 | The paper is a biophysical study on mucus rheology and cough clearance using a model trachea, not a pharmacokinetic study of ceratonia. |
| popPK | King_1987_2 | irrelevant | 0 | 0 | The paper is an in-vitro study on mucus rheology and cough clearance in a model trachea, not a pharmacokinetic study of ceratonia. |
| popPK | Klein_1994 | irrelevant | 0 | 0 | The paper is a review of otitis media management and does not contain any pharmacokinetic data for ceratonia. |
| popPK | Kukati_2018 | irrelevant | 0 | 0 | The study focuses on the formulation of cefpodoxime proxetil tablets using locust bean gum (Ceratonia) as an excipient, not on the pharmacokinetics of Ceratonia itself. |
| PGx | Kyriacou_2021 | not_relevant | 0 | 0 | The paper analyzes the metabolome and antioxidant potential of carob fruit during ripening, not the pharmacokinetics or pharmacodynamics of a drug in humans. |
| PD | Laaraj_2024_2 | not_relevant | 2 | 2 | The paper reports in vitro IC50 values for antioxidant assays and qualitative antibacterial/anticancer activities, but lacks a pharmacokinetic (PK) component or a formal exposure-response (PD) model linking drug concentration in a biological system to a physiological effect. |
| PD | Laaraj_2025 | not_relevant | 2 | 2 | The paper reports in vitro IC50 values for antioxidant and cytotoxic assays, which are single-point potency metrics rather than a pharmacodynamic (exposure-response) model or curve with parameters like Emax, EC50, or slope. |
| PD | Lall_2015 | not_relevant | 0 | 0 | The provided text is only a title and does not contain any data, analysis, or numeric parameters regarding pharmacodynamics or exposure-response relationships. |
| popPK | Lamsen_2020 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of vitamin D3, not ceratonia. |
| popPK | Lee_2025 | irrelevant | 0 | 0 | The paper investigates the mechanism of rifampin-mediated decapsulation of Salmonella Typhi and does not report pharmacokinetic parameters for ceratonia. |
| popPK | Li_2023 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of iron nanoparticles (GA-FeONPs) and does not report any parameters for the drug ceratonia. |
| popPK | Li_2023_2 | irrelevant | 0 | 0 | The study focuses on the fabrication and characterization of nanoparticles for luteolin encapsulation, not the pharmacokinetics of ceratonia. |
| popPK | Liu_2022 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of curcumin, not ceratonia. |
| popPK | Liu_2024 | irrelevant | 0 | 0 | The paper is a review of Astragalus polysaccharide for diabetes treatment and does not contain pharmacokinetic data for ceratonia. |
| popPK | Lu_2018 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of genistein in mice, not ceratonia. |
| popPK | Luanda_2024 | irrelevant | 0 | 0 | The study focuses on the drug release of 5-fluorouracil from a locust bean gum hydrogel, not the pharmacokinetics of ceratonia. |
| popPK | Maag_2022 | irrelevant | 0 | 0 | The paper investigates the food processing properties (solubility, digestibility, thermal stability) of spirulina (Arthrospira platensis) and does not involve the drug ceratonia or any pharmacokinetic parameters. |
| popPK | Macit_2026 | irrelevant | 0 | 0 | The study focuses on in-vitro characterization and biological activity of carob extracts, with no pharmacokinetic parameters reported. |
| popPK | Mehraban_2021 | irrelevant | 0 | 0 | The study investigates the effect of Ceratonia siliqua extract on sperm parameters and DNA fragmentation in mice, not the pharmacokinetics of the drug ceratonia. |
| PD | Mehraban_2021 | not_relevant | 2 | 0 | The study reports qualitative improvements in sperm parameters and DNA fragmentation at a single fixed dose, without providing numeric concentration-effect data, dose-response curves, or derivable PD parameters like Emax or EC50. |
| PD | Meziani_2015 | not_relevant | 0 | 0 | The paper reports antibacterial activity (MICs) of plant extracts against bacteria, which is a microbiological assay, not a pharmacodynamic (exposure-response) relationship for a drug in a host system. |
| popPK | Moumou_2024 | irrelevant | 0 | 0 | The study evaluates the pharmacological effects of carob extract on lipid metabolism and toxicity, but does not report any pharmacokinetic parameters (CL, V, ka, etc.) for the drug. |
| popPK | Msanda_2021 | irrelevant | 0 | 0 | The paper is a floristic and biogeographical study of the Argan tree ecosystem in Morocco and contains no pharmacokinetic data for ceratonia. |
| popPK | Nasir_2008 | irrelevant | 0 | 0 | The study investigates the physiological effects of gum arabic (Acacia senegal) on water and electrolyte balance in mice, not the pharmacokinetics of ceratonia. |
| popPK | Nasir_2012 | irrelevant | 0 | 0 | The study investigates the effects of gum arabic (Acacia senegal) on renal function in mice, not the pharmacokinetics of ceratonia. |
| popPK | Navarro_2022 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of D-Pinitol, not ceratonia (which is only mentioned as a source of the syrup). |
| popPK | Ohno_1995 | irrelevant | 0 | 0 | The study investigates bacterial clearance kinetics in mice and does not involve the drug ceratonia. |
| PD | Oku_2025 | not_relevant | 2 | 1 | The paper reports a single IC50 value (13.32 μg/mL) for a crude extract in an MTT assay, which is a single-point potency metric, not a pharmacodynamic exposure-response or dose-response curve with derivable parameters like Emax or slope. |
| popPK | Paton_2019 | irrelevant | 0 | 0 | The paper is a review of Streptococcus pneumoniae capsule biology and has no relation to the pharmacokinetics of ceratonia. |
| PD | Peng_2023 | not_relevant | 0 | 0 | The paper focuses on the isolation and identification of chemical compounds from carob pods and does not report any pharmacodynamic, exposure-response, or dose-response data. |
| popPK | Qi_2021 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of ibuprofen, not ceratonia. |
| popPK | Sassi_2016 | irrelevant | 0 | 0 | no_text gate: only 153 chars of text extracted (&lt; 400) |
| PD | Serio_2025 | not_relevant | 0 | 0 | The paper is a comprehensive analysis of the bioactive profile and health-promoting potential of carob leaves, focusing on chemical composition and in vitro/in vivo biological activities, but it does not report pharmacokinetic (PK) or pharmacodynamic (PD) modeling, exposure-response relationships, or numeric PD parameters (e.g., Emax, EC50) for a specific drug compound in the context of PK/PD. |
| PGx | Shaker_2025 | not_relevant | 0 | 0 | The study investigates herb-drug interactions and nanoparticle formulation effects on donepezil, not pharmacogenomic effects of ceratonia. |
| popPK | Shalby_2012 | irrelevant | 0 | 0 | The study investigates the anti-inflammatory effects of carob (ceratonia) on cyclosporine-induced renal dysfunction in rats, reporting biochemical markers rather than pharmacokinetic parameters for ceratonia. |
| popPK | Shimizu_1989 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding ceratonia or pharmacokinetics. |
| popPK | Shimizu_1994 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding ceratonia or pharmacokinetics. |
| popPK | Silva_2021 | irrelevant | 0 | 0 | The paper is a review on polysaccharides and cholesterol homeostasis, containing no pharmacokinetic data for ceratonia. |
| popPK | Tang_2024 | irrelevant | 0 | 0 | The paper studies the immunomodulatory effects of selenium-containing peptide nanoparticles in mice and does not involve the drug ceratonia or its pharmacokinetics. |
| popPK | Tayyab_2024 | irrelevant | 0 | 0 | The study focuses on febuxostat, not ceratonia, and reports no PK parameters for the target drug. |
| popPK | Tolve_2021 | irrelevant | 0 | 0 | The paper is an in-vitro study on the microencapsulation and release kinetics of condensed tannins (Quebracho extract) for animal feed, not a pharmacokinetic study of the drug ceratonia. |
| popPK | Tomoda_1993 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding ceratonia or pharmacokinetics. |
| popPK | Tomoda_1994 | irrelevant | 0 | 0 | The provided evidence contains only software metadata and no scientific content regarding ceratonia or pharmacokinetics. |
| PD | Venianakis_2024 | not_relevant | 3 | 3 | The paper reports single-point biological activity metrics (MIC and IC50) for a crude extract but does not provide a dose-response curve, concentration-effect data, or PK/PD modeling parameters. |
| popPK | Wang_2020 | irrelevant | 0 | 0 | The paper describes the formation and characterization of protein-polysaccharide complexes (β-lactoglobulin and gum arabic) and contains no pharmacokinetic data for ceratonia. |
| popPK | Wang_2022 | irrelevant | 0 | 0 | The paper studies the in vitro delivery of resveratrol, not the pharmacokinetics of ceratonia. |
| popPK | Wang_2024 | irrelevant | 0 | 0 | The paper is an in-vitro study on the antioxidant activity and structural characterization of anthocyanin-polysaccharide complexes from Aronia melanocarpa, containing no pharmacokinetic data for ceratonia. |
| popPK | Wu_2024 | irrelevant | 0 | 0 | The paper studies the anti-tumor effects of a polysaccharide-selenium nanoparticle complex in vitro, not the pharmacokinetics of ceratonia. |
| popPK | Xu_2020 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of paclitaxel (PTX), not ceratonia. |
| popPK | Xu_2023 | irrelevant | 0 | 0 | The paper studies selenium nanoparticles for ulcerative colitis and does not involve the drug ceratonia or its pharmacokinetics. |
| popPK | Yoshizawa_1993 | irrelevant | 0 | 0 | The paper studies immunomodulating polysaccharides from marine algae, not the pharmacokinetics of ceratonia. |
| popPK | Yu_2022 | irrelevant | 0 | 0 | The study focuses on the formulation of nanoparticles for lutein delivery and does not report pharmacokinetic parameters for ceratonia. |
| popPK | Zhang_2024 | irrelevant | 0 | 0 | The study focuses on the emulsification properties of buckwheat flower polysaccharides and curcumin bioaccessibility, not the pharmacokinetics of ceratonia. |
| popPK | Zhang_2026 | irrelevant | 0 | 0 | The study investigates the pharmacokinetics of urolithin A, not ceratonia. |

---
<sub>Generated by `docs.py` (scholarv2)</sub>
